This effect is lost as a result of p53 mutations, indicating that wild-type p53 modulates the communication between cancer cells and the tumor microenvironment by driving the phagocytic capacity of tumor-fighting macrophages [84]. The gene discussed is TP53; the disease is neoplasm.